LIPOCINE RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHTue, 26 May 2026 12:19:06 +0200https://images.finanzen.net/images/finanzen_net_neu.gifLIPOCINE RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netLipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)Mon, 12 Jan 2026 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/lipocine-reports-encouraging-progress-post-second-interim-safety-review-in-phase-3-trial-of-lpcn-1154-in-postpartum-depression-ppd-15409046
  • Company on track to report topline results early in the second quarter of 2026
  • Second planned Data and Safety Monitoring Board (DSMB) meeting evaluated all available safety data for the ...

    ]]>https://www.finanzen.net/nachricht/aktien/lipocine-reports-encouraging-progress-post-second-interim-safety-review-in-phase-3-trial-of-lpcn-1154-in-postpartum-depression-ppd-15409046Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment MilestoneTue, 16 Dec 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/lipocine-s-ppd-phase-3-study-lpcn-1154-hits-80-enrollment-milestone-15361789
    • Second Drug Safety Monitoring Board (DSMB) meeting update planned for mid-January 2026
    • Topline results on track for the second quarter of 2026

    ]]>https://www.finanzen.net/nachricht/aktien/lipocine-s-ppd-phase-3-study-lpcn-1154-hits-80-enrollment-milestone-15361789